应用KAP模式对改善β受体阻滞剂在住院冠心病患者中使用情况的临床研究  

Clinical Study on the Use of KAP Mode in Improving the Use ofβ-blockers in Patients with Coronary Heart Disease

作　　者：程俊[1] 宋慧琴 谢丽娟[1] 宋雯雯[1] 骆嵩山 Cheng Jun,et al(Department of Cardiovascular Medicine,Yingde People＇s Hospital, Guangdong Province,Yingde 51300)

机构地区：[1]广东省英德市人民医院心血管内科,英德513000 [2]广东省英德市人民医院老年科

出　　处：《数理医药学杂志》2018年第8期1145-1146,共2页Journal of Mathematical Medicine

摘　　要：目的:分析应用知信行(KAP)模式对改善β受体阻滞剂在住院冠心病患者中使用情况产生的影响。方法:回顾性分析2015年12月~2017年6月300例冠心病住院患者资料,根据是否接受KAP模式分为KAP组和对照组,对比治疗效果。结果:KAP组高危型患者β受体阻滞剂使用率高于对照组患者;KAP组中低危型β受体阻滞剂使用率低于对照组患者;KAP组用药合理性显著高于对照组;KAP组临床治疗效果显著优于对照组,数据差异均具有统计学意义(P<0.05)。结论:应用KAP模式可以有效改善β受体阻滞剂在住院冠心病患者中的使用情况,提高高危型冠心病患者的β受体阻滞剂使用率,降低中低危患者的使用率。Objective：To analyze the effect of the KAP model in improving the use ofβ-blockers in hospitalized patients with coronary heart disease.Methods：The data of 300 inpatients with coronary heart disease from December 2015 to June 2017 were retrospectively analyzed.The patients were divided into KAP group and control group according to whether to accept KAP model,then the treatment effect in the two groups were compared.Results：The utilization rate ofβ-blockers in high-risk patients in KAP group was higher than that in control group.The utilization rate of low risk typeβ-blockers in KAP group was lower than that in control group.The rationality of medication in KAP group was significantly higher than that in control group,and the clinical effect of KAP group was significantly better than that in control group.The differences between the two groups were statistically significant（P〈0.05）.Conclusion：The application of KAP can effectively improve the use ofβ-blockers in hospitalized patients with coronary heart disease,increase the use ofβ-blockers in high-risk patients with coronary heart disease,and reduce the use of patients with low-risk disease.

关 键 词：KAP模式 Β受体阻滞剂 冠心病 使用率 

分 类 号：R541.4[医药卫生—心血管疾病]